Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 457-670-6 | CAS number: 157859-20-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 20 October 2004 to 7 December 2004
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 004
- Report date:
- 2004
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- Triisopropylsilyl acrylate
- Cas Number:
- 157859-20-6
- Molecular formula:
- C12H24O2Si
- IUPAC Name:
- Triisopropylsilyl acrylate
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- other: CBA/CaOlaHsd
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan Netherlands, B.V. Postbus 6174, NL-5960 AD Horst, The Netherlands
- Age at study initiation: 8-12 weeks
- Weight at study initiation: 16-24 g
- Housing: Individually in Makrolon type-2 cages
- Diet: Pelleted standard Kliba 3433 mouse maintenance diet, ad libitum
- Water: Community tap water, ad libitum
- Acclimation period: 6 days under test conditions after health examination
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22+/-3
- Humidity (%): 30-70
- Air changes (per hr): 10-15
- Photoperiod (hrs dark / hrs light):12/12
IN-LIFE DATES: From: 20-Oct-2004 To: 01-Nov-2004
Study design: in vivo (LLNA)
- Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 25, 50 and 100%
- No. of animals per dose:
- 4
- Details on study design:
- RANGE FINDING TESTS:
- Compound solubility: no data
- Irritation: Non-GLP pre-test in two mice, tested at 10, 25, 50 and 100% with acetone:olive oil (4:1) as the vehicle. 24 Hours after a single topical application, 100% (undiluted) was the highest technically applicable concentration while avoiding systemic toxicity and excessive local irritation in the chosen vehicle
- Lymph node proliferation response: not determined
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: local lymph node assay
- Criteria used to consider a positive response: Exposure to at least one concentration of the test item resulted in an incorporation of 3HTdR at least 3-fold or greater than that recorded in control mice (as indicated by the stimulation index) and the data are compatible with a conventional dose response although allowance must be made (especially at high topical concentrations) for either local toxicity or immunological suppression.
TREATMENT PREPARATION AND ADMINISTRATION: 25 µl of propenoic acid, tris(1-methylethyl)silyl ester was applied topically (epidermally) to the entire dorsal surface of each ear lobe (left and right) of each mouse, once daily for 3 consecutive days. A further group of mice, treated with an equivalent volume of the vehicle, acted as the negative control group. A hair dryer was passed briefly over the ear's surface to prevent loss of any of the test item applied. Five days after the first topical application, all mice were administered 250 µl of 80 µCi/ml 3HTdR (equal to 20.0 µCi) by intravenous injection via a tail vein. Approximately 5 hours later, draining auricular lymph nodes were rapidly excised and pooled for each experimental group (8 nodes/group). Single cell suspensions (in phosphate buffered saline) of pooled lymph node cells were prepared by gentle mechanical disaggregation through stainless steel gauze (200 µm mesh size). After washing twice with phosphate buffered saline, the lymph node cells were resuspended in 5% trichloroacetic acid (approximately 3 ml) and incubated at approximately 4°C for at least 18 hours for precipitation of macromolecules. The precipitates were then resuspended in 5% trichloroacetic acid (1 ml) and transferred to glass scintillation vials with 10 ml scintillation liquid and thoroughly mixed. The level of 3HTdR incorporation was then measured in a beta-scintillation counter as the number of radioactive disintegrations per minute (dpm). - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- Statistical analysis conducted for assessment of the dose-response relationship, and the EC3 value was calculated according to the equation:
EC3 = (a-c) [(3-d)/(b-d)] + c
where EC3 = estimated concentration of the test item required to produce a 3-fold increase in draining lymph node cell proliferation activity i.e. a Stimulation Index (SI) of 3;
(a, b) and (c, d) = respective co-ordinates of the two pair of data lying immediately below and above the S.I. value of 3 on the local lymph node assay dose reponse plot.
Results and discussion
- Positive control results:
- No clinical signs were seen in any animal treated with 5% alpha-hexylcinnamaldehyde when compared with the corresponding control group. A slight ear erythema occurred on the second application day at both dosing sites in all mice treated with 10 or 25% concentrations (with the exception of 1 animal), which persisted for the remainder of the in-life phase of the study or for a total of 3 days, separately. On the second application day, a slight ear swelling was observed at both dosing sites in all mice treated with 25%, persisting for the remainder of the in-life phase of the study or for a total of 3 days, separately. The stimulation indices for the 5, 10 and 25% test concentrations were 2.7, 3.4 and 12.4 respectively, showing a clear dose-response relationship. The EC3 (the estimated concentration of test item required to produce a stimulation index of 3) was 7.1% (w/v). As a test item is regarded as a sensitizer in the LLNA if the exposure to one or more test concentrations resulted in a 3-fold or greater increase in incorporation of 3HTdR compared with concurrent controls, as indicated by the stimulation index, alpha-hexylcinnamaldehyde responded as expected for a positive control i.e. it was found to be a skin sensitizer.
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Value:
- 2.2
- Test group / Remarks:
- 25%
- Parameter:
- SI
- Value:
- 1.8
- Test group / Remarks:
- 50%
- Parameter:
- SI
- Value:
- 4.9
- Test group / Remarks:
- 100%
- Parameter:
- EC3
- Remarks:
- % (w/v)
- Value:
- 69.4
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: see Remark
- Remarks:
- Measured disintegrations per minute: 0, 4337, 9656, 7670, 21259 for the background (1 ml of 5% trichloroacetic acid), control, 25, 50 and 100% groups respectively. Disintegrations per minute per lymph node: 542, 1207, 959 and 2657 for the control, 25, 50 and 100% groups respectively.
Any other information on results incl. tables
No deaths occurred during the study, there were no symptoms of local toxicity at the ears of the animals and no systemic findings during the study period. Body weights, recorded prior to the first application and prior to necropsy, were within the range commonly recorded for animals of this strain and age.
Applicant's summary and conclusion
- Interpretation of results:
- Category 1B (indication of skin sensitising potential) based on GHS criteria
- Conclusions:
- In a local lymph node assay in mice, conducted according to OECD test guideline 429 and in compliance with GLP, tri(isopropyl)silyl acrylate was tested at 25, 50 and 100% and found to be a skin sensitizer (Stimulation Index ≥3 at 100%) with an EC3 value of 69.4%.
- Executive summary:
Tri(isopropyl)silyl acrylater was tested in a local lymph node assay, conducted to OECD test guideline 429 and in compliance with GLP.
Test material (25 µl of 25, 50 or 100%
in acetone/olive oil was topically applied to the entire dorsal surface of each ear lobe of groups of 4 female mice, daily for 3 consecutive days. Five days after the first topical application, 3H-methyl thymidine was injected intravenously into a tail vein and, approximately 5 hours later, mice were sacrificed, draining auricular lymph nodes excised, pooled per group and the incorporation of 3H-methyl thymidine measured.
All treated animals survived the study period and no clinical signs of toxicity were observed. The stimulation indices for the 25, 50 and 100% treatment groups were 2.2, 1.8 and 4.9 respectively.
Tri(isopropyl)silyl acrylate was found to be a skin sensitizer (SI ≥3 at 100%) with an EC3 value of 69.4% under the conditions of the test.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.